BSC
RPRX icon

BOLTON SECURITIES CORPORATION’s Royalty Pharma RPRX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2K Buy
+234
New +$10.2K ﹤0.01% 1587
2025
Q3 		$8.26K Buy
+234
New +$8.47K ﹤0.01% 1593

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's RPRX Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Royalty Pharma (RPRX) in Q1 2026: 234 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in RPRX as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in RPRX in Q3 2025 and has held it in 2 quarters since. 595 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 234 shares of Royalty Pharma worth $11.2K as of Q1 2026.
  • Royalty Pharma was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Royalty Pharma made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1587 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Royalty Pharma in Q3 2025 and has held it in 2 quarters since.
  • 595 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.